FDAClass IIMay 4, 2022

Losartan Potassium 50 mg Tablet recall: Impurity Out of Spec

Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin…

Why was Losartan Potassium 50 mg Tablet recalled?

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # B1467803-120621, exp. date 06/30/2022 Lot # J0585793-121721, exp. date 12/31/2022

Product
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin…
Recalling firm
RemedyRepack Inc.
Quantity
433/30 count blister cards, 33/60 count blister cards
Distribution
Product was distributed to customers in AK and PA.
Recall date
May 4, 2022
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls